{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:46:55Z","timestamp":1774129615291,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3841,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1111\/j.1523-1755.2005.09502.x","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T13:58:47Z","timestamp":1115387927000},"page":"S13-S20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S95","title":["Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Charles R.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeh Y.","family":"Qunibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0015","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1111\/j.1523-1755.2005.09502.x_bb0020","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/jarr.2002.34846","article-title":"Pathogenesis of parathyroid dysfunction in end-stage renal disease","volume":"9","author":"Silver","year":"2002","journal-title":"Adv Renal Replacement Ther"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0030","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiology"},{"issue":"Suppl 2","key":"10.1111\/j.1523-1755.2005.09502.x_bb0035","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for nutrition in chronic renal failure","volume":"35","author":"National Kidney Foundation","year":"2000","journal-title":"Am J Kidny Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0055","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ndt\/13.9.2303","article-title":"Effect of RenaGel, a non-absorbed, calcium- and aluminum-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients","volume":"13","author":"Goldberg","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0065","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","article-title":"Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)","volume":"65","author":"Qunibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0070","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1523-1755.2004.00877.x","article-title":"A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States","volume":"66","author":"Mann","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000169030","article-title":"Hypocalcemia, morbidity, and mortality in end-stage renal disease","volume":"16","author":"Foley","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0085","first-page":"18","article-title":"A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients","volume":"51","author":"Chertow","year":"1999","journal-title":"Clin Nephrol"},{"issue":"Suppl 82","key":"10.1111\/j.1523-1755.2005.09502.x_bb0090","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.62.s82.15.x","article-title":"Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon","volume":"62","author":"Qunibi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0095","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","article-title":"BMP-7 is an efficacious treatment of vascular calcification in murine models of atherosclerosis and chronic renal failure","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0100","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0105","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0110","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in hemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro and in vivo study","volume":"83","author":"Sheikh","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0120","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJM198708273170903","article-title":"Gastrointestinal absorption of calcium from milk and calcium salts","volume":"317","author":"Sheikh","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000072822","article-title":"The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients","volume":"23","author":"Chertow","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0135","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","article-title":"Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography","volume":"339","author":"Callister","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0140","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.CIR.0000027567.49283.FF","article-title":"Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation","volume":"106","author":"Achenbach","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0145","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/ndt\/gfh338","article-title":"Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in hemodialysis patients","volume":"19","author":"Nitta","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0150","series-title":"Drug Topic 2003 Redbook, Montvale, NJ, Thomson PDR","year":"2003"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0155","first-page":"F836","article-title":"Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis","volume":"256","author":"Bushinsky","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00041552-200007000-00008","article-title":"The effects of acid on bone","volume":"9","author":"Bushinsky","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0165","doi-asserted-by":"crossref","first-page":"C1364","DOI":"10.1152\/ajpcell.1995.269.6.C1364","article-title":"Additive effects of acidosis and parathyroid hormone on mouse osteoblastic and osteoclastic function","volume":"269","author":"Bushinsky","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0170","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1172\/JCI118566","article-title":"The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway","volume":"97","author":"Bailey","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.09502.x_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI117668","article-title":"Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans","volume":"95","author":"Ballmer","year":"1995","journal-title":"J Clin Invest"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:44:45Z","timestamp":1758761085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815508028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":34,"alternative-id":["S0085253815508028"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09502.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09502.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}